ARICEPT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ARICEPT contains one active pharmaceutical ingredient (API):

1	Donepezil UNII 3O2T2PJ89D - DONEPEZIL HYDROCHLORIDE
	Donepezil hydrochloride is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain. Donepezil hydrochloride is in vitro over 1000 times more potent an inhibitor of this enzyme than of butyrylcholinesterase, an enzyme that is present mainly outside the central nervous system.
	Read more about Donepezil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ARICEPT Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
ARICEPT Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06DA02	Donepezil	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11922L, 11924N, 2479L, 2532G, 8495D, 8496E
CA	Health Products and Food Branch	02232043, 02232044, 02269457, 02269465
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00432774, 01086268, 01603864, 01603870, 01699539, 02475150, 02953514, 03552562, 06705960, 08490512, 08490529, 08490535, 08490558, 08490564, 08490570, 09722551, 13248351, 13826210, 15881561
EE	Ravimiamet	1030374, 1030385
ES	Centro de información online de medicamentos de la AEMPS	1-22057, 3400937306447, 61869, 61870, 68213, 68214, 75519, 76110, 76110-4-12-2006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	454439, 454686
FR	Base de données publique des médicaments	62262995, 62650485, 69050347, 69972923
GB	Medicines & Healthcare Products Regulatory Agency	111334, 111337, 141965, 141967, 161390, 161392, 175330, 26950, 26956
HK	Department of Health Drug Office	42885, 42889, 58711, 58712, 61846
HR	Agencija za lijekove i medicinske proizvode	HR-H-615262859, HR-H-681092208
IE	Health Products Regulatory Authority	13013, 13080
IT	Agenzia del Farmaco	033254018, 033254020, 033254210, 033254309
JP	医薬品医療機器総合機構	1190012C1020, 1190012F1026, 1190012F2022, 1190012F3029, 1190012F4025, 1190012F5021, 1190012F6028, 1190012Q1027, 1190012Q2023, 1190012Q3020, 1190012R1022
NZ	Medicines and Medical Devices Safety Authority	12007, 12008, 7917, 7918
PL	Rejestru Produktów Leczniczych	100079234, 100079240, 100335810, 100358419
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64846001, W64846002, W64847001, W64847002
SG	Health Sciences Authority	09957P, 09958P, 13645P, 13646P, 14575P
TN	Direction de la Pharmacie et du Médicament	8013042, 8013045
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308071002, 8681308071019, 8681308091062, 8681308091079, 8681308091086, 8681308096708
US	FDA, National Drug Code	55289-151, 62856-245, 62856-246, 62856-247, 62856-831, 62856-832
ZA	Health Products Regulatory Authority	32/5.3/0315, 32/5.3/0316